Premium
Design, synthesis, and anticancer activities of sodium quinazolin‐4‐diselenide compounds
Author(s) -
Zhang Yuchun,
Niu Pengpeng,
Wen Quanwu,
Sun Lin,
Wang Weili,
Xu Shengguang,
Liu Gang
Publication year - 2020
Publication title -
journal of heterocyclic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.321
H-Index - 59
eISSN - 1943-5193
pISSN - 0022-152X
DOI - 10.1002/jhet.3743
Subject(s) - diselenide , chemistry , quinazoline , hela , sodium , proton nmr , diphenyl diselenide , cancer cell lines , combinatorial chemistry , stereochemistry , cancer cell , organic chemistry , selenium , cancer , biochemistry , cell , medicine
Substituted 4‐chloroquinazoline reacted with sodium diselenide to give novel sodium quinazoline‐4‐diselenide compounds. The reaction provides an efficient and facile approach to the synthesis of sodium quinazoline‐4‐diselenide compounds. Structures of title compounds were confirmed by IR, 1 H NMR, 13 C NMR, and elemental analysis. MTT assay was adopted to show anticancer activities of the compounds. Compounds 5a and 5h showed good activities against cancer‐cell lines MDA‐MB‐435, MDA‐MB‐231, A549, SiHa, and HeLa. In addition, 5a exhibited quite good anticancer effects on relative above cell lines with 10μ M concentration compared with oxaliplatin and gefitinib of the commercial anticancer drugs.